Amerise Biosciences
₹0.6
13 May, 2024 07:00 BSE: 531681
NSE: AMERISEISIN: INE673C01020
Start SIP in Amerise Biosciences
Start SIPAmerise Biosciences Performance
Day Range
- Low 0
- High 0
52 Week Range
- Low 0
- High 0
- Open Price0
- Previous Close0
- Volume
Amerise Biosciences Financials
Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|
Oper Rev Qtr Cr | 0 | 0 | 0 | 0 |
Operating Expenses Qtr Cr | 0 | 0 | 0 | 0 |
Operating Profit Qtr Cr | 0 | 0 | 0 | 0 |
Depreciation Qtr Cr | 0 | 0 | 0 | 0 |
Interest Qtr Cr | 0 | 0 | 0 | 0 |
Tax Qtr Cr | 0 | 0 | 0 | 0 |
Net Profit Qtr Cr | 0 | 0 | 0 | 0 |
Amerise Biosciences Technicals
EMA & SMA
Current Price
₹0.6
+0 (0%)
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- ₹0.63
- 50 Day
- ₹0.66
- 100 Day
- ₹0.68
- 200 Day
- ₹0.71
- 20 Day
- ₹0.62
- 50 Day
- ₹0.67
- 100 Day
- ₹0.72
- 200 Day
- ₹0.67
Amerise Biosciences Resistance and Support
PIVOT
₹0.61
Resistance | |
---|---|
First Resistance | 0.61 |
Second Resistance | 0.63 |
Third Resistance | 0.63 |
RSI | 37.62 |
MFI | 38.96 |
MACD Single Line | -0.02 |
MACD | -0.02 |
Support | |
---|---|
First Resistance | 0.59 |
Second Resistance | 0.59 |
Third Resistance | 0.57 |
Amerise Biosciences Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 32,240 | 3,224,000 | 100 |
Week | 55,051 | 5,057,022 | 91.86 |
1 Month | 69,029 | 6,404,525 | 92.78 |
6 Month | 126,924 | 11,834,406 | 93.24 |
Amerise Biosciences Result Highlights
Amerise Biosciences Synopsis
BSE-Medical-Biomed/Biotech
Amerise Biosciences belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 0.00 Cr. and Equity Capital is Rs. 6.61 Cr. for the Year ended 31/03/2023. Amerise Biosciences Ltd. is a Public Limited Listed company incorporated on 27/08/1984 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L29199GJ1984PLC007195 and registration number is 007195.Market Cap | 4 |
Sales | |
Shares in Float | 6.61 |
No of funds | |
Yield |
Book Value | 0.71 |
U/D Vol ratio | 0.9 |
LTDebt / Equity | 2 |
Alpha | -0.09 |
Beta | 0.75 |
Amerise Biosciences
Owner Name | Mar-24 | Dec-23 | Sep-23 | Jun-23 |
---|---|---|---|---|
Promoters | ||||
Individual Investors | 72.32% | 72.32% | 72.44% | 72.37% |
Others | 27.68% | 27.68% | 27.56% | 27.63% |
Amerise Biosciences Management
Name | Designation |
---|---|
Mr. Dineshkumar Tribhovanbhai Rathod | WholeTime Director & CFO |
Ms. Manisha Maneklal Patel | Director |
Mr. Niraj Vaghela | Director |
Amerise Biosciences Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Amerise Biosciences Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-01-22 | Quarterly Results | |
2023-11-07 | Quarterly Results | |
2023-08-08 | Quarterly Results | |
2023-05-04 | Audited Results | |
2023-01-25 | Quarterly Results |
Amerise Biosciences FAQs
What is Share Price of Amerise Biosciences ?
Amerise Biosciences share price is ₹0 As on 13 May, 2024 | 06:46
What is the Market Cap of Amerise Biosciences ?
The Market Cap of Amerise Biosciences is ₹4 Cr As on 13 May, 2024 | 06:46
What is the P/E ratio of Amerise Biosciences ?
The P/E ratio of Amerise Biosciences is -21.3 As on 13 May, 2024 | 06:46
What is the PB ratio of Amerise Biosciences ?
The PB ratio of Amerise Biosciences is 0.7 As on 13 May, 2024 | 06:46